Clinical trial
Citalopram to Enhance Cognition in HD
NCT00271596 · University of Iowa, Other · Completed
Key facts
| NCT number | NCT00271596 |
|---|---|
| Title | Citalopram to Enhance Cognition in HD |
| Official title | A Randomized, Placebo-Controlled Pilot Study in Huntington's Disease (CIT-HD) |
| Acronym | CIT-HD |
| Lead sponsor | University of Iowa, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH Cure Huntington's Disease Initiative (CHDI) University of Rochester Mayo Clinic |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Huntington Disease, Chorea, Executive Dysfunction |
| Intervention type | Drug |
| Interventions | 20mg daily citalopram, Placebo |
| Enrollment | 33 |
| Start date | Nov 1, 2005 |
| Primary completion | Apr 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Jan 2, 2006 |
| Last update posted | Mar 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: